Want more information about the fight to reform New York’s lawsuit system? You’ve come to the right place.
Last week, the U.S. Supreme Court issued its highly anticipated opinion in Wyeth v. Levine and ruled that federal law does NOT pre-empt Levine’s claim that Wyeth did not adequately warn about the dangers of the IV-push method of administering their drug, Phenergan.
This decision opens up the possibility of lawsuits all across the nation, as plaintiffs and their lawyers argue that drug manufacturers should be held liable under various state laws for accidents and errors resulting from the use of products deemed safe by the Food and Drug Administration. Rather than have one, professional decision making body regulating the safe use of drugs and medical devises in the nation, the Court has now put the 50 states in charge of determining the safety of medical products through their various laws.
You can read the Washington Post story about the decision here, and the Supreme Court’s decision here.
A Texas Turnaround: The Impact of Lawsuit Reform on Business Activity in the Lone Star State
Institute Ranks New York
Annual Guide to State Litigation. A review of the
legal climates in all 50 states
Here’s a copy of the Pacific Research Institute’s report on New York’s lawsuit system. For more information, including the press release announcing the study, go the media materials section. Articles of interest are located there as well as in the News blog.
To see a complete list of legislative memorandums that NYLR and its predecessor organization (NYTortReformNOW) have published, click here.